Elevated hyaluronan concentration without hyaluronidase activation in malignant epithelial ovarian tumors

Cancer Research

Volumn 62, Issue 22, 2002, Pages 6410-6413

  Hiltunen, Essi L J ^a   Anttila, Maarit ^a   Kultti, Anne ^a   Ropponen, Kirsi ^a   Penttinen, Jorma ^a   Yliskoski, Merja ^a   Kuronen, Arja T ^b   Juhola, Matti ^b   Tammi, Raija ^a   Tammi, Markku ^a   Kosma, Veli Matti ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; HYALURONIDASE;

ANGIOGENESIS; ARTICLE; BENIGN TUMOR; CANCER GRADING; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CARCINOMA; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN DETERMINATION; STAINING;

ADULT; AGED; AGED, 80 AND OVER; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FEMALE; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; MIDDLE AGED; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; STAINING AND LABELING;

EID: 0037112521     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Tammi, M. I., Day, A. J., and Turley, E. A. Hyaluronan and homeostasis: A balancing act. J. Biol. Chem., 277: 4581-4584, 2002
2. Llaneza, A., Vizoso, F., Rodriguez, J. C., Raigoso, P., Garcia-Muniz, J. L., Allende, M. T., and Garcia-Moran, M. Hyaluronic acid as prognostic marker in resectable colorectal cancer. Br. J. Surg., 87: 1690-1696, 2000
3. Lokeshwar, V. B., Rubinowicz, D., Schroeder, G. L., Forgacs, E., Minna, J. D., Block, N. L., Nadji, M., and Lokeshwar, B. L. Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer. J. Biol. Chem., 276: 11922-11932, 2001
4. Itano, N., Atsumi, F., Sawai, T., Yamada, Y., Miyaishi, O., Senga, T., Hamaguchi, M., and Kimata, K. Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration. Proc. Natl. Acad. Sci. USA, 99: 3609-3614, 2002
5. Toole, B. P., Wight, T. N., and Tammi, M. I. Hyaluronan-cell interactions in cancer and vascular disease. J. Biol. Chem., 277: 4593-4596, 2002
6. Rilla, K., Lammi, M. J., Sironen, R, Törrönen, K., Luukkonen, M., Hascall, V. C., Midura, R. J., Hyttinen, M., Pelkonen, J., Tammi, M., and Tammi, R. Changed lamellipodial extension, adhesion plaques, and migration in epidermal keratinocytes containing constitutively expressed sense and antisense hyaluronan synthase 2 (HAS2) genes. J. Cell. Sci., 115: 3633-3643, 2002
7. Montesano, R., Kumar, S., Orci, L., and Pepper, M. S. Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro. Lab. Investig., 75: 249-262, 1996
8. Liu, D., Pearlman, E., Diaconu, E., Guo, K., Mori, H., Haqqi, T., Markowitz, S., Willson, J., and Sy, M. S. Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proc. Natl. Acad. Sci. USA, 93: 7832-7837, 1996
9. Lokeshwar, V. B., Lokeshwar, B. L., Pham, H. T., and Block, N. L. Association of elevated levels of hyalurouidase, a matrix-degrading enzyme, with prostate cancer progression. Cancer Res., 56: 651-657, 1996
10. Pham, H. T., Block, N. L., and Lokeshwar, V. B. Tumor-derived hyaluronidase: A diagnostic urine marker for high-grade bladder cancer. Cancer Res., 57: 778-783, 1997
11. Bertrand, P., Girard, N., Duval, C., d’Anjou, J., Chauzy, C., Menard, J. F., and Delpech, B. Increased hyaluronidase levels in breast tumor metastases. Int. J. Cancer, 73: 327-331, 1997
12. Anttila, M. A., Tammi, R. H., Tammi, M. I., Syrjanen, K. J., Saarikoski, S. V., and Kosma, V. M. High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. Cancer Res., 60: 150-155, 2000
13. Cancer Committee of the International Federation of Gynecology and Obstetrics. Staging announcement: FIGO Cancer Committee. Gynecol. Oncol., 25: 383-385, 1986
14. Serov, S. F., Scully, R., and Sobin, L. H. Histological typing of ovarian tumours. In: International Histological Classification of Tumors, No. 9. Geneva: WHO. 1973
15. Chichibu, K., Matsuura, T., Shichijo, S., and Yokoyama, M. M. Assay of serum hyaluronic acid in clinical application. Clin. Chin. Acta. 181: 317-323, 1989
16. Wang, C., Tammi, M., Guo, H., and Tammi, R. Hyaluronan distribution in the normal epithelium of esophagus, stomach, and colon and their cancers. Am. J. Pathol., 148: 1861-1869, 1996
17. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976
18. Melrose, J., Numata, Y., and Ghosh, P. Biotinylated hyaluronan: A versatile and highly sensitive probe capable of detecting nanogram levels of hyaluronan binding proteins (hyaladherins) on electroblots by a novel affinity detection procedure. Electrophoresis, 17: 205-212, 1996
19. Frost, G. I., and Stern. R. A microtiter-based assay for hyaluronidase activity not requiring specialized reagents. Anal. Biochem., 251: 263-269, 1997
20. Isogai, Z., Shinomura, T., Yamakawa, N., Takeuchi, J., Tsuji, T., Heinegard, D., and Kimata, K. 2BI antigen characteristically expressed on extracellular matrices of human malignant tumors is a large chondroitin sulfate proteoglycan, PG-M/versican. Cancer Res., 56: 3902-3908, 1996
21. Csoka, A. B., Frost, G. I., and Stern, R. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol., 20: 499-508, 2001
22. Wei, M. H., Latif, F., Bader, S., Kashuba, V., Chen, J. Y., Duh, F. M., Sekido, Y., Lee, C. C., Geil, L., Kuzmin, I., Zabarovsky, E., Klein, G., Zbar, B., Minna, J. D., and Lerman, M. I. Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3: progress toward the isolation of a lung cancer TSG. Cancer Res., 56: 1487-1492, 1996
23. Mullegger, J., and Lepperdinger, G. Degradation of hyaluronan by a Hyal2-type hyaluronidase affects pattern formation of vitelline vessels during embryogenesis of Xenopus laevis. Mech. Dev., 111: 25-35, 2002
24. Rai, S. K., Duh, F. M., Vigdorovich, V., Danilkovitch-Miagkova, A., Lerman, M. I., and Miller, A. D. Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Proc. Natl. Acad. Sci. USA, 98: 4443-4448, 2001